UK to pull pseudoephedrine
Drugs containing pseudoephedrine and ephedrine could soon be reclassified as prescription-only the UK, in proposals drawn up last week by the Medicines and Healthcare Products Regulatory Agency (MHRA).
Drugs containing pseudoephedrine and ephedrine could soon be reclassified as prescription-only the UK, in proposals drawn up last week by the Medicines and Healthcare Products Regulatory Agency (MHRA).
Schering-Plough took the industry by surprise this morning when it unveiled an €11bn bid to buy European rival Organon from Akzo Nobel.
Qualicaps, Eurotherm, Acambis, Invetech have all had people on the move in the world of pharmaceutical manufacturing.
10 major pharmaceutical companies are taking part in an international data-sharing initiative to drive down the need for animal testing.